139 related articles for article (PubMed ID: 11944956)
1. [131I]MIBG radionuclide therapy in carcinoid syndrome.
Taal BG; Zuetenhorst H; Valdés Olmos RA; Hoefnagel CA
Eur J Surg Oncol; 2002 Apr; 28(3):243. PubMed ID: 11944956
[No Abstract] [Full Text] [Related]
2. (131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome.
Pathirana AA; Vinjamuri S; Byrne C; Ghaneh P; Vora J; Poston GJ
Eur J Surg Oncol; 2001 Jun; 27(4):404-8. PubMed ID: 11417988
[TBL] [Abstract][Full Text] [Related]
3. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
[TBL] [Abstract][Full Text] [Related]
4. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
[TBL] [Abstract][Full Text] [Related]
5. 131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status.
Tepmongkol S; Heyman S
Med Pediatr Oncol; 1999 Jun; 32(6):427-31; discussion 432. PubMed ID: 10358701
[TBL] [Abstract][Full Text] [Related]
6. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
[TBL] [Abstract][Full Text] [Related]
7. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
[TBL] [Abstract][Full Text] [Related]
8. Carcinoid tumors.
Taal BG; Hoefnagel C; Rutgers M
N Engl J Med; 1999 Aug; 341(6):454; author reply 454-5. PubMed ID: 10438271
[No Abstract] [Full Text] [Related]
9. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA
Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046
[TBL] [Abstract][Full Text] [Related]
10. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
[TBL] [Abstract][Full Text] [Related]
11. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
Hoefnagel CA; Taal BG; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoid tumor metastases visualized by I-MIBG. Report of 5 cases].
Mey P; Minier JF
Ann Radiol (Paris); 1990; 33(4-5):237-9. PubMed ID: 2268126
[No Abstract] [Full Text] [Related]
13. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
[TBL] [Abstract][Full Text] [Related]
14. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
Bestagno M
J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
[No Abstract] [Full Text] [Related]
15. Enhanced tumor uptake in neuroendocrine tumors after intraarterial application of 131I-MIBG.
Brogsitter C; Pinkert J; Bredow J; Kittner T; Kotzerke J
J Nucl Med; 2005 Dec; 46(12):2112-6. PubMed ID: 16330578
[TBL] [Abstract][Full Text] [Related]
16. The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE
Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit.
Hanson MW; Schneider AM; Enterline DS; Feldman JM; Gockerman JP
J Nucl Med; 1998 Apr; 39(4):647-50. PubMed ID: 9544672
[TBL] [Abstract][Full Text] [Related]
18. mIBG diagnosis and therapy in smooth muscle tumours of the small bowel.
Akle CA; Wardle DG; Bomanji JB; Talbot I
Eur J Nucl Med; 1997 Sep; 24(9):1196. PubMed ID: 9378175
[No Abstract] [Full Text] [Related]
19. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
[TBL] [Abstract][Full Text] [Related]
20. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]